← All trials
NCT05944627
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 6, 2023
- Primary completion
- Mar 31, 2024
- Completion date
- Feb 28, 2026
- First posted
- Jul 13, 2023
- Last posted
- Jul 14, 2023
- Enrollment
- 68
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Kang Stem Biotech Co., Ltd.Lead sponsor
- Kyung Hee UniversityOverall official - principal investigator
- Kyung Hee UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.